IVIg vs placebo or no intervention
28‐Day all cause mortality (adult studies) · adult patients with sepsis, severe sepsis and septic shock
Polyclonal intravenous immunoglobulin (IVIG) probably leads to lower all‐cause mortality, adults, standard polyclonal IVIG compared with placebo or no intervention (moderate certainty).
5 findings from 1 review
- Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock 2013 · Cochrane Headline outcomes onlyRR 0.81 [0.7, 0.93]10 studies · 1430 participantsModerate
- Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock 2013 · Cochrane Headline outcomes onlyRR 0.66 [0.51, 0.85]7 studies · 528 participantsModerate
- Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock 2013 · Cochrane Headline outcomes onlyRR 0.97 [0.81, 1.15]5 studies · 945 participantsHigh
Show 2 more findings
- Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock 2013 · Cochrane Headline outcomes onlyRR 1.02 [0.84, 1.24]3 studies · 683 participantsHigh
- Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock 2013 · Cochrane Headline outcomes onlyRR 0.82 [0.56, 1.19]2 studies · 262 participantsModerate